Company Filing History:
1 out of 1,430 
1 out of 348 Years Active: 1995
Title: Masanao Oda – Innovator in Ribozyme Technology
Introduction
Masanao Oda is a notable inventor recognized for his contributions to the field of ribozyme technology. Residing in Tsukuba, Japan, Oda has a keen focus on innovations that enhance the stability and efficiency of ribozymes, which are crucial in molecular biology and therapeutic applications.
Latest Patents
Oda holds a patent titled "Hammerhead ribozymes with enhanced stability provided by an additional 3' h - A DNA fragment." This innovation discloses a method of connecting a downstream DNA sequence that includes elements coding for a second ribozyme RNA. The second ribozyme RNA can cleave itself from the 3'-terminus site of the first ribozyme RNA during transcription. This creates an efficient system for producing ribozymes with self-processed 3'-terminus sites, significantly contributing to advancements in genetic research and therapeutic techniques.
Career Highlights
Throughout his career, Masanao Oda has worked with prominent organizations, including the Agency of Industrial Science and Technology and the Ministry of International Trade and Industry. His roles in these institutions have allowed him to impact the scientific community significantly, facilitating the development of innovative biotechnological solutions.
Collaborations
Oda's groundbreaking research has included collaborations with esteemed colleagues, such as Kazunari Taira and Hideaki Shinshi. Together, they have contributed to the understanding and application of ribozyme technologies, further bridging the gap between academic research and practical applications in the biopharmaceutical industry.
Conclusion
Masanao Oda's contributions to ribozyme technology exemplify the innovative spirit driving advancements in molecular biology. With a patented technology that enhances the stability and functionality of ribozymes, Oda's work continues to influence research and development in the field, paving the way for future innovations that may transform therapeutic approaches and genetic engineering practices.